Eupraxia Pharmaceuticals Inc.

NASDAQ:EPRX

Biotechnology

Healthcare
$6.62 +1.11%

+$0.07 today

Market cap
$445.14M
Beta
1.48
P/E (TTM)
-8.5
EPS (TTM)
-$0.74
52W Low $4.19High $9.32

Volume 1.64M

Average 0.22M

Price history

Eupraxia Pharmaceuticals Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+3.92%

Period high

$9.10

Period low

$5.81

Latest

$6.62

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
S-8Nov 12, 2026Nov 12, 2026
6-KNov 10, 2026Nov 10, 2026
SUPPLNov 10, 2026Nov 10, 2026
6-KNov 10, 2026Nov 10, 2026
6-KNov 10, 2026Nov 10, 2026
6-KNov 10, 2026Nov 10, 2026
6-KOct 22, 2026Oct 22, 2026
6-KOct 15, 2026Oct 15, 2026
6-KOct 9, 2026Oct 9, 2026
6-KSep 30, 2026Sep 30, 2026
6-KSep 8, 2026Sep 8, 2026
SUPPLSep 2, 2026Sep 1, 2026
EFFECTAug 24, 2026Aug 25, 2026
F-10/AAug 19, 2026Aug 19, 2026
SC 13G/AAug 13, 2026Aug 13, 2026

Competitors

Who does Eupraxia Pharmaceuticals Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about EPRX's filings, answered from its disclosures.

What is the latest EPRX filing?

The latest filing shown is S-8 dated Nov 12, 2026.

How many recent filings does EPRX have?

Intrinsic Alpha currently shows 20 recent filings for EPRX.